In cases of DLBCL, immunohistochemical staining for BCL2 and c-MYC identifies “double expresser” lymphomas, a subgroup associated with a poor prognosis, though not as severe as double-hit lymphomas [53,54]. The gene discussed is MYC; the disease is lymphoma.